mTOR inhibitors
mTOR inhibitors are a class of medications that block a protein called mTOR, which plays a key role in cell growth, division, and metabolism. By inhibiting mTOR, these drugs can slow down the growth of certain types of cancer cells and reduce inflammation. They are often used in treating some cancers, organ transplant rejections, and specific diseases like tuberous sclerosis. Examples of mTOR inhibitors include everolimus and sirolimus. Their use is based on their ability to interfere with cellular processes that can lead to disease progression.
Additional Insights
-
mTOR inhibitors are a class of medications that block a protein called mTOR, which plays a crucial role in cell growth, metabolism, and aging. By inhibiting mTOR, these drugs can slow down the growth of cancer cells, reduce inflammation, and may have benefits for certain age-related conditions. They are often used in cancer treatment, organ transplantation to prevent rejection, and to address rare diseases. Common mTOR inhibitors include drugs like rapamycin and everolimus. Their targeted action helps improve patient outcomes by regulating harmful cell proliferation while sparing healthy cells.